• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

无症状 COVID-19 与年轻成年人中的 ST 段抬高型心肌梗死：两例相似病例中获得的经验教训。

Asymptomatic COVID-19 and ST-elevation myocardial infarction in young adults: lessons learned from two similar cases.

机构信息

Clinic of General and Invasive Cardiology, University Hospital #1, Yerevan State Medical University, Koryun Street 2, Yerevan, 375025, Armenia.

出版信息

ESC Heart Fail. 2022 Feb;9(1):775-781. doi: 10.1002/ehf2.13690. Epub 2021 Nov 14.

DOI:10.1002/ehf2.13690
PMID:34779152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8653304/
Abstract

We present two cases of acute myocardial infarction in young patients with asymptomatic COVID-19 infection and ST-elevation myocardial infarction (STEMI), complicated by severe acute heart failure and ventricular fibrillation, resulting cardiopulmonary resuscitation and mechanical ventilatory support. Urgent primary percutaneous coronary intervention with further complex treatment was effective in both cases with critical cardiovascular state and co-morbid COVID-19 infection. This report illustrates the challenges in clinical severity of STEMI with COVID-19 infection, despite of young age and absence of clinical symptoms and chronic co-morbidities. STEMI patients with even asymptomatic COVID-19 infection may be presented with significantly higher rates of severe acute heart failure.

摘要

我们报告了两例 COVID-19 感染无症状的年轻急性心肌梗死（STEMI）患者，并发严重急性心力衰竭和心室颤动，导致心肺复苏和机械通气支持。在这种危急心血管状态和合并 COVID-19 感染的情况下，紧急进行经皮冠状动脉介入治疗（PCI）并进行进一步的复杂治疗，对两种情况均有效。本报告说明了 COVID-19 感染合并 STEMI 的临床严重程度的挑战，尽管患者年龄较轻且无临床症状和慢性合并症。即使 COVID-19 感染无症状的 STEMI 患者也可能出现更高比例的严重急性心力衰竭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/1cfcafc6b86e/EHF2-9-775-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/9dc8a76699d6/EHF2-9-775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/60ae8343907d/EHF2-9-775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/9a1332756ea4/EHF2-9-775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/3cedff39213c/EHF2-9-775-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/c6755365ce09/EHF2-9-775-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/02b3c089f853/EHF2-9-775-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/735e531e41a4/EHF2-9-775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/1cfcafc6b86e/EHF2-9-775-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/9dc8a76699d6/EHF2-9-775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/60ae8343907d/EHF2-9-775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/9a1332756ea4/EHF2-9-775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/3cedff39213c/EHF2-9-775-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/c6755365ce09/EHF2-9-775-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/02b3c089f853/EHF2-9-775-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/735e531e41a4/EHF2-9-775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60bc/8788047/1cfcafc6b86e/EHF2-9-775-g008.jpg

相似文献

1
Asymptomatic COVID-19 and ST-elevation myocardial infarction in young adults: lessons learned from two similar cases.无症状 COVID-19 与年轻成年人中的 ST 段抬高型心肌梗死：两例相似病例中获得的经验教训。
ESC Heart Fail. 2022 Feb;9(1):775-781. doi: 10.1002/ehf2.13690. Epub 2021 Nov 14.
2
Silent Myocardial Infarction and Acute Multiorgan Failure in a COVID-19 Patient: A Case Report.COVID-19 患者的无症状性心肌梗死和急性多器官功能衰竭：病例报告。
JNMA J Nepal Med Assoc. 2021 Oct 15;59(242):1048-1051. doi: 10.31729/jnma.6933.
3
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19.新型冠状病毒肺炎合并 ST 段抬高型心肌梗死的研究进展
Cardiol Clin. 2022 Aug;40(3):321-328. doi: 10.1016/j.ccl.2022.03.007. Epub 2022 Mar 29.
4
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.COVID-19 患者中 ST 段抬高型心肌梗死血栓负荷高。
J Am Coll Cardiol. 2020 Sep 8;76(10):1168-1176. doi: 10.1016/j.jacc.2020.07.022. Epub 2020 Jul 14.
5
Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.COVID-19 患者发生 ST 段抬高型心肌梗死，巨大冠状动脉血栓导致经皮冠状动脉介入治疗失败。
Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E667-E669. doi: 10.1002/ccd.29050. Epub 2020 May 30.
6
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.COVID-19 大流行期间的 ST 段抬高型心肌梗死：区域性公共服务医疗中心的观察结果。
Circ Cardiovasc Interv. 2020 Aug;13(8):e009413. doi: 10.1161/CIRCINTERVENTIONS.120.009413. Epub 2020 Aug 14.
7
Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry).新型冠状病毒肺炎疫情对土耳其 ST 段抬高型心肌梗死（STEMI）患者的影响：TURSER 研究（土耳其 ST 段抬高型心肌梗死注册研究）结果。
J Thromb Thrombolysis. 2022 Feb;53(2):321-334. doi: 10.1007/s11239-021-02487-3. Epub 2021 May 29.
8
Initial Single-Center ST-Segment Elevation Myocardial Infarction Experience in New York Before and During the COVID-19 Pandemic.在 COVID-19 大流行前后纽约的初始单中心 ST 段抬高型心肌梗死经验。
Cardiovasc Revasc Med. 2022 Jan;34:80-85. doi: 10.1016/j.carrev.2021.01.026. Epub 2021 Jan 26.
9
Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021.COVID-19 大流行期间的 STEMI 管理：2020 年汲取的经验教训，为 2021 年做准备。
Trends Cardiovasc Med. 2021 Apr;31(3):135-140. doi: 10.1016/j.tcm.2020.12.003. Epub 2020 Dec 15.
10
Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.2019冠状病毒病大流行期间ST段抬高型心肌梗死的治疗
Cardiovasc Revasc Med. 2020 Aug;21(8):1024-1029. doi: 10.1016/j.carrev.2020.05.027. Epub 2020 May 21.

引用本文的文献

1
Acute Myocardial Infarction From Embolized Left Ventricular Thrombus in Coronavirus Disease 2019.2019冠状病毒病中左心室血栓栓塞所致急性心肌梗死
J Nurse Pract. 2022 Sep;18(8):904-909. doi: 10.1016/j.nurpra.2022.05.008. Epub 2022 Jun 15.

本文引用的文献

1
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence.既往健康状况与严重 COVID-19 结局：全球证据的伞式评价方法和荟萃分析。
BMC Med. 2021 Aug 27;19(1):212. doi: 10.1186/s12916-021-02058-6.
2
Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic.年龄调整后合并症与 COVID-19 结局的相关性：从大流行早期阶段的证据综述。
Front Public Health. 2021 Aug 6;9:584182. doi: 10.3389/fpubh.2021.584182. eCollection 2021.
3
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
用于 SARS-CoV-2 感染诊断的快速、即时抗原和基于分子的检测。
Cochrane Database Syst Rev. 2021 Mar 24;3(3):CD013705. doi: 10.1002/14651858.CD013705.pub2.
4
Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.新冠病毒 19 型合并 ST 段抬高型心肌梗死患者的直接经皮冠状动脉介入治疗或溶栓治疗
Am J Cardiol. 2020 Nov 1;134:158. doi: 10.1016/j.amjcard.2020.08.021. Epub 2020 Aug 22.
5
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.COVID-19 患者中 ST 段抬高型心肌梗死血栓负荷高。
J Am Coll Cardiol. 2020 Sep 8;76(10):1168-1176. doi: 10.1016/j.jacc.2020.07.022. Epub 2020 Jul 14.
6
The cytokine storm and COVID-19.细胞因子风暴与 COVID-19。
J Med Virol. 2021 Jan;93(1):250-256. doi: 10.1002/jmv.26232. Epub 2020 Sep 30.
7
Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.特稿——COVID-19 感染住院患者的急性心肌损伤：综述。
Prog Cardiovasc Dis. 2020 Sep-Oct;63(5):682-689. doi: 10.1016/j.pcad.2020.05.013. Epub 2020 Jun 6.
8
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.COVID-19 住院患者死亡的预测因素：系统评价和荟萃分析。
J Med Virol. 2020 Oct;92(10):1875-1883. doi: 10.1002/jmv.26050. Epub 2020 Jul 11.
9
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.SARS-CoV-2 的受体 ACE-2 在许多不同的细胞类型上表达：对基于 ACE 抑制剂和血管紧张素 II 受体阻滞剂的心血管治疗的影响。
Intern Emerg Med. 2020 Aug;15(5):759-766. doi: 10.1007/s11739-020-02364-6. Epub 2020 May 19.
10
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.